Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis-Reference-Cited by-同舟云学术

Discovery and pre-clinical characterization of a selective PI3Kδ inhibitor, LL-00071210 in rheumatoid arthritis

Published:2022-07 Issue: Volume:927 Page:175054
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kanoje Vijay,Pandey Dilip,Wagh Akshaya,Patra Sukanya,Kumar Marisetti Ajit,Reddy Madhusudhan,Samant Charudatt,Mahajan Nilesh,Gholve Milind^ORCID,Sabde Sudeep,Trivedi Sneha,Bhankhede Trupti,Patil Vinod,Nigade Prashant,Modi Dipak,Mehta Maneesh,Ahirrao Prajakta,Tota Swathi^ORCID,Nanda Bidyut,Pawar Shashikant,Polawar Anuradha,Tamane Kaustubh,Kuldharan Sandip,Vishwase Gururaj^ORCID,Jana Nirmal,Mahangare Sachin J.,Vidhate Prashant,Lagad Dipak,Gundu Jayasagar,Phukan Samiron,Shukla Manojkumar,Narasimham Lakshmi,Nemmani Kumar V.S.,Bhonde Mandar,Sharma Sharad,Kamboj Rajender K.,Palle Venkata P.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage;Angulo;Science,2013

2. PI3K inhibitors as potential therapeutics for autoimmune disease;Ball;Drug Discov. Today,2014

3. The therapeutic potential for PI3K inhibitors in autoimmune rheumatic diseases;Banham-Hall;Open Rheumatol. J.,2012

4. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding;Banker;J. Pharm. Sci.,2003

5. PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis;Bartok;Am. J. Pathol.,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions;Molecular Cancer;2024-08-10

2. Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking;Computational Biology and Chemistry;2024-04

3. A need for clinical trial: re-purposing the Monoamine Oxidase Inhibitors (MAO-I) for rheumatoid arthritis (RA);Inflammopharmacology;2023-08-09